Novartis Inks $840 Million Collaboration and Option Deal with IFM Due

Life Science

AstraZeneca’s Tagrisso Approved in China as First-Line Lung Cancer Treatment

Life Science

Quan Capital Closes Second Healthcare Fund at $275 Million

Life Science

China loosens curbs on small, unapproved drug imports

Life Science

Innovent Acquires China Rights to Novel Diabetes Drug from Lilly

Life Science

Pfizer Investing $500 Million in North Carolina Gene Therapy Facility, Adding 300 Jobs

Life Science

Trump administration proposes making it easier for doctors to know whether patient has addiction history

Life Science

US Medical Device Maker Thermo Fisher to Build New China Factory

Life Science, Technology

CStone to Begin Australian Trials of Solid Tumor Cancer Drug

Life Science

Luye Pharma Approved to Start Japan Trials of Novel Anti-depressant

Life Science

Yaoyanshe Raises $42 Million for On-Line CRO/CMO Services

Life Science

Kintor Pharma Starts CDMO Cooperation with CMAB for ALK-1 Cancer Drug

Life Science

Abbisko Approved to Start US Trial of CSF-1R Immunotherapy

Life Science

Alligator Bioscience Signs Antibody Agreement for Greater China with Biotheus Inc.

Life Science

China’s LHHC Signs Up Vancouver’s Enlighta to Market AI Early Test for Cancer

Life Science